A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence
Open accessThe DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Background: The translation of evidence on dementia risk factors into clinical advice requires careful evaluation of the methodology and scope of data from which risk estimates are obtained. Objective: To evaluate the quantity, quality, and representativeness of evidence, we conducted a review of reviews of risk factors for Alzheimer’s disease (AD), Vascular dementia (VaD), and Any Dementia. Methods: PubMed, Cochrane library, and the Global Index Medicus were searched to identify meta-analyses of observational studies of risk factors for AD, VaD, and Any Dementia. PROSPERO CRD42017053920. Results: Meta-analysis data were available for 34 risk factors for AD, 26 risk factors for Any Dementia and eight for VaD. Quality of evidence varied greatly in terms of the number of contributing studies, whether data on midlife exposure was available, and consistency of measures. The most evidence was available for cardiovascular risk factors. The most geographically representative evidence (five of six global regions) was available for alcohol, physical activity, diabetes, high midlife BMI, antihypertensives, and motor function. Evidence from Australia/Oceana or Africa was limited. With the exception of diabetes, meta-analysis data were unavailable from Latin America/Caribbean. Midlife specific data were only available for cholesterol and arthritis. Conclusion: There is a lack of midlife specific data, limited data on VaD, and a lack of geographical representation for many risk factors for dementia. The quality, quantity, and representativeness of evidence needs to be considered before recommendations are made about the relevance of risk factors in mid- or late-life or for dementia subtypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“No association was found between obesity and VaD11”
From Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction (2019) · cites this paper as [11]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cohort studies of dementia risk factors and therefore metaanalyses are overwhelmingly from HICs, and within these cohorts, recruit people of European origin, more education, and higher socioeconomic status, and more usually of older age groups with few people from minority ethnic groups. (33)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We used worldwide figures of prevalence where possible, which include disproportionate numbers from HICs although we have included evidence that risk factors prevalence varies between countries.(32) (33)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most research data for this calculation came from HIC and there is a relative absence of specific evidence of the impact of risk factors on dementia risk in LMIC, particularly from Africa and Latin America.27”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High adherence to a Mediterranean diet was shown to reduce risk across all five NCDs by between 4% and 36%,11,77,90,93,98”
From Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction (2019) · cites this paper as [11]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000055 · Cited by 2,587 · cited 1×
“A systematic review of reviews was con77 ducted [9], and pre-registered in PROSPERO 78 CRD42017053920.”
BackgroundSystematic review finds overlapping reviews were not mentioned in every other overview
Pieper, D., Antoine, S.-L., Mathes, T., Neugebauer, E. A. M., & Eikermann, M. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.007 · Cited by 1,318
Diniz, B. S., Butters, M. A., Albert, S. M., Dew, M. A., & Reynolds, C. F. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.118307 · Cited by 1,290
Kuiper, J. S., Zuidersma, M., Oude Voshaar, R. C., Zuidema, S. U., van den Heuvel, E. R., Stolk, R. P., & Smidt, N. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.006 · Cited by 1,090
Cheng, G., Huang, C., Deng, H., & Wang, H. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02758.x · Cited by 1,040
Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence
Hamer, M., & Chida, Y. (2009) · Psychological Medicine · doi:10.1017/s0033291708003681 · Cited by 988
National Collaborating Centre for Mental Health
Veale, D. M. (2006) · Research Portal (King's College London) · Cited by 941
Blondell, S. J., Hammersley-Mather, R., & Veerman, J. L. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-510 · Cited by 928
Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm116 · Cited by 921
Self-citationAnstey, K. J., Cherbuin, N., Budge, M., & Young, J. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00825.x · Cited by 855 · cited 12×
“…3.14) – – 4 Meng 2014 [61] Obese versus normal ML 1.88 (1.32, 2.69) 59.1% 0.55 5 Beydoun 2008 [45] Obese versus normal ML/LL 1.80 (1.00, 3.29) – <0.01 4 Anstey 2011 [17] Obese versus not Obese LL 1.46 (0.97, 2.21) 42.3% ∼ 2 Anstey 2011 [17] Overweight versus normal ML/LL 1.35 (1.19, 1.54)…”
BackgroundInfluentialSelf-citationDiabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies
Gudala, K., Bansal, D., Schifano, F., & Bhansali, A. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12087 · Cited by 727 · cited 3×
“Gudala 2013 [65] Type II diabetes (self-reported, registrybased/antidiabetics use) ML/LL 1.”
InfluentialChatterjee, S., Peters, S. A. E., Woodward, M., Mejia Arango, S., Batty, G. D., Beckett, N., Beiser, A., Borenstein, A. R., Crane, P. K., Haan, M., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1588 · Cited by 711
Self-citationSleep, Cognitive impairment, and Alzheimer's disease: a systematic review and meta-analysis
Bubu, O. M., Brannick, M., Mortimer, J., Umasabor-Bubu, O., Sebastião, Y. V., Wen, Y., Schwartz, S., Borenstein, A. R., Wu, Y., Morgan, D., et al. (2017) · Sleep · doi:10.1093/sleep/zsw032 · Cited by 673 · cited 1×
“3% ∼ 8 Sleep Bubu 2016 [58] All sleep problems/disorders listed in International Classification of Sleep Disorders versus none ML/LL 1.”
BackgroundSingh, B., Parsaik, A. K., Mielke, M. M., Erwin, P. J., Knopman, D. S., Petersen, R. C., & Roberts, R. O. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-130830 · Cited by 665
A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement
Chen, Y., Yang, K., Marušić, A., Qaseem, A., Meerpohl, J. J., Flottorp, S., Akl, E. A., Schünemann, H. J., Chan, E. S. Y., Falck-Ytter, Y., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1565 · Cited by 665
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
LeBlanc, E. S., Janowsky, J., Chan, B. K. S., & Nelson, H. D. (2001) · JAMA · doi:10.1001/jama.285.11.1489 · Cited by 659
Meta-analysis of modifiable risk factors for Alzheimer's disease
Xu, W., Tan, L., Wang, H.-F., Jiang, T., Tan, M.-S., Tan, L., Zhao, Q.-F., Li, J.-Q., Wang, J., & Yu, J.-T. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310548 · Cited by 573 · cited 10×
“Xu 2015 [20] Folate-high serum folate levels LL/? 0.”
BackgroundInfluentialBeydoun, M. A., Beydoun, H. A., & Wang, Y. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00473.x · Cited by 563
Etminan, M., Gill, S., & Samii, A. (2003) · BMJ · doi:10.1136/bmj.327.7407.128 · Cited by 511
Pedditizi, E., Peters, R., & Beckett, N. (2016) · Age and Ageing · doi:10.1093/ageing/afv151 · Cited by 474
Self-citationAlcohol, dementia and cognitive decline in the elderly: a systematic review
Peters, R., Peters, J., Warner, J., Beckett, N., & Bulpitt, C. (2008) · Age and Ageing · doi:10.1093/ageing/afn095 · Cited by 453 · cited 2×
“1.10 (0.94, 1.29) 93.5% 0.53 7 Zhong 2015 [22] Former versus never LL 1.04 (0.96, 1.13) 2.8% 0.01 13 Xu 2015 [20] Former versus never 1.00 (0.92, 1.08) 0.0% 0.27 9 Peters 2008 [59] Former versus never ?”
InfluentialSelf-citationAnstey, K. J., Mack, H. A., & Cherbuin, N. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a2fd07 · Cited by 452
Self-citationPerry, D. C., Sturm, V. E., Peterson, M. J., Pieper, C. F., Bullock, T., Boeve, B. F., Miller, B. L., Guskiewicz, K. M., Berger, M. S., Kramer, J. H., et al. (2016) · Journal of Neurosurgery · doi:10.3171/2015.2.jns14503 · Cited by 440
Cognitive Impairment Associated With Atrial Fibrillation: A Meta-analysis
Kalantarian, S., Stern, T. A., Mansour, M., & Ruskin, J. N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00007 · Cited by 425
Diabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-Analysis
Lu, F.-P., Lin, K.-P., & Kuo, H.-K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004144 · Cited by 398 · cited 1×
“Lu 2009 [15] Type II diabetes (medical history, laboratory test, antidiabetic medications) LL 1.”
BackgroundNonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review
Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C. S., & Goodman, S. N. (2004) · Neuroepidemiology · doi:10.1159/000078501 · Cited by 397
An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease
Zhang, J., Chen, C., Hua, S., Liao, H., Wang, M., Xiong, Y., & Cao, F. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.024 · Cited by 376
Zhong, G., Wang, Y., Zhang, Y., Guo, J. J., & Zhao, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118333 · Cited by 362
Anstey, K. J., Ashby-Mitchell, K., & Peters, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160826 · Cited by 360 · cited 5×
“…(0.57, 0.73) 6.7% 0.81 6 Carotid atherosclerosis Xu 2015 [20] Yes versus no (carotid medina wall thickness) 1.65 (1.03, 2.26) 31.1% ∼ 2 Cholesterol Anstey 2017 [63] High cholesterol (>6.5 mmol/l) versus non-high-midlife ML 2.14 (1.33, 3.44) 12.9% ∼ 3 Meng 2014 [61] High cholesterol (>6.5…”
BackgroundInfluentialSelf-citationSmoking, dementia and cognitive decline in the elderly, a systematic review
Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L., & Bulpitt, C. (2008) · BMC Geriatrics · doi:10.1186/1471-2318-8-36 · Cited by 333
Self-citationZhang, Y., Chen, J., Qiu, J., Li, Y., Wang, J., & Jiao, J. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.124081 · Cited by 330
The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
Koyama, A., O'Brien, J., Weuve, J., Blacker, D., Metti, A. L., & Yaffe, K. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls187 · Cited by 322
Vagelatos, N. T., & Eslick, G. D. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs012 · Cited by 320 · cited 3×
“6% – 4 Vagelatos 2013 [16] Type II diabetes, self-report and blood sampling ML/LL 1.”
BackgroundInfluentialEducation and dementia: a meta-analytic study
Caamaño-Isorna, F., Corral, M., Montes-Martínez, A., & Takkouche, B. (2006) · Neuroepidemiology · doi:10.1159/000093378 · Cited by 288 · cited 1×
“Caamano-Isorna 2006 [18] Lower versus highest levels adj 1.”
BackgroundPedditzi, E., Peters, R., & Beckett, N. (2016) · Age and Ageing · doi:10.1093/ageing/afw095 · Cited by 279
Self-citationWang, J., Tan, L., Wang, H.-F., Tan, C.-C., Meng, X.-F., Wang, C., Tang, S.-W., & Yu, J.-T. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141506 · Cited by 266
Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies
Xu, W., Tan, L., Wang, H.-F., Tan, M.-S., Tan, L., Li, J.-Q., Zhao, Q.-F., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9211-5 · Cited by 258
Risk Factors and Preventive Interventions for Alzheimer Disease: State of the Science
Daviglus, M. L., Plassman, B. L., Pirzada, A., Bell, C. C., Bowen, P. E., Burke, J. R., Connolly, E. S., Dunbar-Jacob, J. M., Granieri, E. C., McGarry, K., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.100 · Cited by 252
Statins and Cognitive Function: A Systematic Review
Richardson, K., Schoen, M., French, B., Umscheid, C. A., Mitchell, M. D., Arnold, S. E., Heidenreich, P. A., Rader, D. J., & deGoma, E. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-10-201311190-00007 · Cited by 250
Hypertension is a potential risk factor for vascular dementia: systematic review
Sharp, S. I., Aarsland, D., Day, S., Sønnesyn, H., Alzheimer's Society Vascular Dementia Systematic Review Group, & Ballard, C. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2572 · Cited by 241
Li, Y., Li, Y., Li, X., Zhang, S., Zhao, J., Zhu, X., & Tian, G. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169650 · Cited by 241
Swiger, K. J., Manalac, R. J., Blumenthal, R. S., Blaha, M. J., & Martin, S. S. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.07.013 · Cited by 234
Cherbuin, N., Kim, S., & Anstey, K. J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008853 · Cited by 231
Self-citationPesticide exposure and risk of Alzheimer’s disease: a systematic review and meta-analysis
Yan, D., Zhang, Y., Liu, L., & Yan, H. (2016) · Scientific Reports · doi:10.1038/srep32222 · Cited by 231
Dietary Patterns and Risk of Dementia: a Systematic Review and Meta-Analysis of Cohort Studies
Cao, L., Tan, L., Wang, H.-F., Jiang, T., Zhu, X.-C., Lu, H., Tan, M.-S., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9516-4 · Cited by 230
Insomnia and risk of dementia in older adults: Systematic review and meta-analysis
Almondes, K. M. D., Costa, M. V., Malloy-Diniz, L. F., & Diniz, B. S. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.021 · Cited by 229
Power, M. C., Weuve, J., Gagne, J. J., McQueen, M. B., Viswanathan, A., & Blacker, D. (2011) · Epidemiology · doi:10.1097/ede.0b013e31822708b5 · Cited by 213 · cited 9×
“01 6 Power 2011 [68] Per 10 mmHg DBP ML 0.”
BackgroundInfluentialIoannidis, J. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-097621 · Cited by 188
Association between Stroke and Alzheimer's Disease: Systematic Review and Meta-Analysis
Zhou, J., Yu, J.-T., Wang, H.-F., Meng, X.-F., Tan, C.-C., Wang, J., Wang, C., & Tan, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140666 · Cited by 184
Hearing loss and the risk of dementia in later life
Ford, A. H., Hankey, G. J., Yeap, B. B., Golledge, J., Flicker, L., & Almeida, O. P. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.03.004 · Cited by 184
Loef, M., & Walach, H. (2013) · Obesity · doi:10.1002/oby.20037 · Cited by 178
Ein Instrument zur Erstellung von Leitlinienberichten: das RIGHT-Statement
Chen, Y., Yang, K., Marušić, A., Qaseem, A., Meerpohl, J. J., Flottorp, S., Akl, E. A., Schünemann, H. J., Chan, E. S. Y., Falck-Ytter, Y., et al. (2017) · Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2017.10.008 · Cited by 176
Almeida, O. P., Hulse, G. K., Lawrence, D., & Flicker, L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00016.x · Cited by 175
Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: A meta-analysis
Wu, S., Ding, Y., Wu, F., Li, R., Hou, J., & Mao, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.008 · Cited by 166
Physical Activity and Alzheimer Disease: A Protective Association
Santos-Lozano, A., Pareja-Galeano, H., Sanchis-Gomar, F., Quindós-Rubial, M., Fiuza-Luces, C., Cristi-Montero, C., Emanuele, E., Garatachea, N., & Lucia, A. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.024 · Cited by 164
Xu, W., Wang, H. F., Wan, Y., Tan, C.-C., Yu, J.-T., & Tan, L. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014706 · Cited by 164
Hyperhomocysteinemia and Alzheimer's disease: A systematic review
Van Dam, F., & Van Gool, W. A. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2008.03.009 · Cited by 162
Beckett, M. W., Ardern, C. I., & Rotondi, M. A. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0007-2 · Cited by 161
Meng, X.-F., Yu, J.-T., Wang, H.-F., Tan, M.-S., Wang, C., Tan, C.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140954 · Cited by 150 · cited 5×
“14) – – 4 Meng 2014 [61] Obese versus normal ML 1.”
BackgroundInfluentialLv, W., Du, N., Liu, Y., Fan, X., Wang, Y., Jia, X., Hou, X., & Wang, B. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9315-y · Cited by 147
Preventing Cognitive Decline and Dementia: A Way Forward
Committee on Preventing Dementia and Cognitive Impairment, Board on Health Sciences Policy, Division, H. A. M., & National Academies of Sciences, E. (2017) · National Academies Press eBooks · doi:10.17226/24782 · Cited by 142
Liu, Q., Wu, Y., Cheng, H., Xia, T., Ding, H., Wang, H., Wang, Z., & Xu, Y. (2016) · Nutrition · doi:10.1016/j.nut.2015.11.015 · Cited by 134
Shen, L., & Ji, H.-F. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0063-7 · Cited by 126
Wong, W. B., Lin, V. W., Boudreau, D., & Devine, E. B. (2013) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3381 · Cited by 124
Alzheimer's disease and coffee: a quantitative review
Quintana, J. L. B., Allam, M. F., Del Castillo, A. S., & Navajas, R. F.-C. (2007) · Neurological Research · doi:10.1179/174313206x152546 · Cited by 110
Prevention and Treatment of Dementia or Alzheimer’s Disease by Statins: A Meta-Analysis
Zhou, B., Teramukai, S., & Fukushima, M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000099037 · Cited by 100
Inverse Association Between Serum Uric Acid Levels and Alzheimer’s Disease Risk
Du, N., Xu, D., Hou, X., Song, X., Liu, C., Chen, Y., Wang, Y., & Li, X. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9271-6 · Cited by 95
Chang-Quan, H., Hui, W., Chao-min, W., Zheng-Rong, W., Jun-Wen, G., Yong-Hong, L., Yan-You, L., & Qing-Xiu, L. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02810.x · Cited by 89
Tully, P. J., Hanon, O., Cosh, S., & Tzourio, C. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000868 · Cited by 82
O'Brien, J., Jackson, J. W., Grodstein, F., Blacker, D., & Weuve, J. (2014) · Epidemiologic Reviews · doi:10.1093/epirev/mxt008 · Cited by 79
Association between Cancer and Alzheimer's Disease: Systematic Review and Meta-Analysis
Ma, L.-L., Yu, J.-T., Wang, H.-F., Meng, X.-F., Tan, C.-C., Wang, C., & Tan, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140168 · Cited by 68
Caffeine Intake from Coffee or Tea and Cognitive Disorders: A Meta-Analysis of Observational Studies
Kim, Y.-S., Kwak, S. M., & Myung, S.-K. (2015) · Neuroepidemiology · doi:10.1159/000371710 · Cited by 66
Guan, J.-W., Huang, C.-Q., Li, Y.-H., Wan, C.-M., You, C., Wang, Z.-R., Liu, Y.-Y., & Liu, Q.-X. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-111160 · Cited by 66
Impact of Insulin Sensitizers on the Incidence of Dementia: A Meta-Analysis
Ye, F., Luo, Y.-J., Xiao, J., Yu, N.-W., & Yi, G. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000445941 · Cited by 46
Wu, Y., Pei, Y., Wang, F., Xu, D., & Cui, W. (2016) · Scientific Reports · doi:10.1038/srep31975 · Cited by 42
Brookmeyer, R., Kawas, C. H., Abdallah, N., Paganini‐Hill, A., Kim, R. C., & Corrada, M. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.004 · Cited by 40
Longer Duration of Sleep and Risk of Cognitive Decline: A Meta-Analysis of Observational Studies
Kim, H.-B., Myung, S.-K., Lee, S.-M., Park, Y. C., & The Korean Meta-Analysis (KORMA) Study Group (2016) · Neuroepidemiology · doi:10.1159/000454737 · Cited by 39
Xu, G., Bai, F., Lin, X., Wang, Q., Wu, Q., Sun, S., Jiang, C., Liang, Q., & Gao, B. (2017) · BioMed Research International · doi:10.1155/2017/4368474 · Cited by 37
Brief Report: Meta-analysis of Antacid Use and Alzheimer’s Disease
Virk, S. A., & Eslick, G. D. (2015) · Epidemiology · doi:10.1097/ede.0000000000000326 · Cited by 25
Thyrotropin and Alzheimer’s Disease Risk in the Elderly: a Systematic Review and Meta-Analysis
Wang, Y., Sheng, Q., Hou, X., Wang, B., Zhao, W., Yan, S., Wang, Y., & Zhao, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9078-x · Cited by 6
Research works printed but not linked: 2
- Xu W, 2015, J Neurol Neurosurg Psychiatry, 86, 1299
- 10.3233/jad-141506 · DOI · Paper page
Cited by
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
“27 Calculations considering country-specific prevalence of the nine potentially modifiable risk factors indicate PAF of 40% in China, 41% in India and 56% in Latin America with the potential for these numbers to be even higher depending on which estimates of risk factor frequency are used.”
RetractedDementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Shi, L., Steenland, K., Li, H., Liu, P., Zhang, Y., Lyles, R. H., Requia, W. J., Ilango, S. D., Chang, H. H., Wingo, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27049-2 · Cited by 239
Peters, R., Ee, N., Peters, J., Beckett, N., Booth, A., Rockwood, K., & Anstey, K. J. (2019) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622319880392 · Cited by 213
Self-citationEffect of the COVID-19 pandemic on obesity and its risk factors: a systematic review
Nour, T. Y., & Altıntaş, K. H. (2023) · BMC Public Health · doi:10.1186/s12889-023-15833-2 · Cited by 200
Metadata
- Authors
- Anstey, K. J., Ee, N., Eramudugolla, R., Jagger, C., & Peters, R.
- Affiliations
- UNSW Sydney (AU)
- Neuroscience Research Australia (AU)
- Newcastle University (GB)
- Corresponding author
- Anstey, Kaarin J.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2019-08-06
- Volume
- 70
- Issue
- s1
- Pages
- S165-S186
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC6700718
- OpenAlex
- W2957844664
- Cited by
- 187
- References
- 84
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 35 · 2023: 31 · 2022: 31 · 2021: 23 · 2020: 14 · 2019: 2
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- Neuroscience Research Australia
- Dementia Centre for Research Collaboration
- Medical Research Council (MR/J50001X/1)
- National Health and Medical Research Council (1102694)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia risk factors, Alzheimer's disease
- MeSH terms
- Dementia, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


